4//SEC Filing
Eckard Jonathan 4
Accession 0000899243-22-031349
CIK 0001537917other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:00 PM ET
Size
20.2 KB
Accession
0000899243-22-031349
Insider Transaction Report
Form 4
Eckard Jonathan
Director
Transactions
- Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−150,000→ 0 totalExercise: $2.90Exp: 2023-11-07→ Common Stock (150,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−500,000→ 0 totalExercise: $4.31Exp: 2028-03-22→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−370,700→ 0 totalExercise: $1.56Exp: 2030-05-06→ Common Stock (370,700 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−150,000→ 0 totalExercise: $2.90Exp: 2029-05-02→ Common Stock (150,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−300,000→ 0 totalExercise: $1.39Exp: 2032-04-21→ Common Stock (300,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−431,000→ 0 totalExercise: $1.43Exp: 2032-04-21→ Common Stock (431,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−482,200→ 0 totalExercise: $0.32Exp: 2032-04-21→ Common Stock (482,200 underlying)
Footnotes (7)
- [F1]This option was fully vested and assumed by Syros Pharmaceuticals, Inc. ("Syros") in its merger with the issuer and replaced with an option to purchase 21,910 shares of Syros common stock for $98.36 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the "Reverse Split").
- [F2]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 6,573 shares of Syros common stock for $66.18 per share, after giving effect to the Reverse Split.
- [F3]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 6,573 shares of Syros common stock for $66.18 per share, after giving effect to the Reverse Split.
- [F4]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 16,244 shares of Syros common stock for $35.60 per share, after giving effect to the Reverse Split.
- [F5]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 13,146 shares of Syros common stock for $31.72 per share, after giving effect to the Reverse Split.
- [F6]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 18,886 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split.
- [F7]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,130 shares of Syros common stock for $7.30 per share, after giving effect to the Reverse Split.
Documents
Issuer
TYME TECHNOLOGIES, INC.
CIK 0001537917
Entity typeother
Related Parties
1- filerCIK 0001723096
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:00 PM ET
- Size
- 20.2 KB